Comparison Study of Insulin GZR4 With Insulin Degludec
ConditionType 2 Diabetes
Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18-70
SponsorGan and Lee Pharmaceuticals, USA
About this trial
In this study, the investigational product will be compared with insulin degludec (Tresiba®) and insulin icodec (Awiqli®). The comparator products are approved for the treatment of T2DM in the European Union.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- GZR4 injection
Treatment groups
14 Participants
are divided into 1 treatment groupSponsors and collaborators
Gan and Lee Pharmaceuticals, USA
Lead sponsor
Profil Institut für Stoffwechselforschung GmbH
Collaborator
Source ClinicalTrials.gov